entyce
Generic: capromorelin oral solution
entyce: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ARATANA THERAPEUTICS, INC. (PETX) | Approved |
Get deeper analysis on entyce
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis